UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (14) 14
humans (13) 13
life sciences & biomedicine (13) 13
biological and medical sciences (9) 9
hematologic and hematopoietic diseases (9) 9
medical sciences (9) 9
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (8) 8
hematology (7) 7
aged (6) 6
middle aged (6) 6
adult (5) 5
chronic lymphocytic leukemia (5) 5
female (5) 5
male (5) 5
aged, 80 and over (4) 4
animals (4) 4
b-lymphocytes - immunology (4) 4
leukemia, lymphocytic, chronic, b-cell - immunology (4) 4
leukemia, lymphocytic, chronic, b-cell - pathology (4) 4
lymphoma (4) 4
oncology (4) 4
abridged index medicus (3) 3
apoptosis (3) 3
autoimmunity (3) 3
general & internal medicine (3) 3
leukemia (3) 3
leukemia, lymphocytic, chronic, b-cell - genetics (3) 3
lymphocytes (3) 3
medicine, general & internal (3) 3
antigens (2) 2
b lymphocytes (2) 2
b-lymphocytes - pathology (2) 2
cancer (2) 2
cell activation (2) 2
chronic lymphatic leukemia (2) 2
chronic lymphocytic leukaemia (2) 2
disease (2) 2
dosage and administration (2) 2
drug therapy (2) 2
flow cytometry (2) 2
follow-up studies (2) 2
gene expression regulation, neoplastic (2) 2
general aspects (2) 2
genetics (2) 2
hematology, oncology and palliative medicine (2) 2
immunoglobulin variable region - genetics (2) 2
immunology (2) 2
leukemia - therapy (2) 2
leukemia, lymphocytic, chronic, b-cell - drug therapy (2) 2
leukemia, lymphocytic, chronic, b-cell - mortality (2) 2
lymphatic leukemia (2) 2
lymphocytes b (2) 2
lymphomas (2) 2
mice (2) 2
patients (2) 2
recurrence (2) 2
signal transduction (2) 2
survival (2) 2
survival analysis (2) 2
t-lymphocytes - immunology (2) 2
tumor cells, cultured (2) 2
tumor microenvironment (2) 2
tumors (2) 2
abl1 (1) 1
acids (1) 1
adp-ribosyl cyclase 1 - analysis (1) 1
agammaglobulinaemia tyrosine kinase (1) 1
aging - immunology (1) 1
analysis (1) 1
anemia (1) 1
antibiotics. antiinfectious agents. antiparasitic agents (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized (1) 1
antigen presenting cells (1) 1
antigens, bacterial - immunology (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antiviral agents (1) 1
apoptosis - immunology (1) 1
autoantigens - metabolism (1) 1
autoimmune diseases (1) 1
autoimmune diseases - diagnosis (1) 1
autoimmune diseases - immunology (1) 1
autoimmune diseases - therapy (1) 1
autoimmunity - genetics (1) 1
b cell receptor (1) 1
b-cells (1) 1
b-lymphocytes - metabolism (1) 1
biotechnology & applied microbiology (1) 1
blood (1) 1
blood diseases (1) 1
blood platelets (1) 1
bruton's tyrosine kinase (1) 1
care and treatment (1) 1
cd20 antigen (1) 1
cd4-positive t-lymphocytes - immunology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Antiviral agents | General aspects | Pharmacology. Drug treatments | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Lymphoma | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 3, pp. 213 - 223
Journal Article
Journal Article